{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:02:30Z","timestamp":1789567350593,"version":"build-2803163510"},"reference-count":281,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01GM152585"],"award-info":[{"award-number":["R01GM152585"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Pelotonia Institute of Immuno-Oncology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Biol"],"DOI":"10.1186\/s13059-026-04284-8","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:16:56Z","timestamp":1789557416000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Decoding the cancer microbiome: multi-omics, AI, and translational opportunities"],"prefix":"10.1186","volume":"27","author":[{"given":"Yuhan","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia J.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Shabnaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aik Choon","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3264-8392","authenticated-orcid":false,"given":"Qin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"issue":"1","key":"4284_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13045-024-01640-8","volume":"17","author":"Z Wu","year":"2024","unstructured":"Wu Z, Xia F, Lin R. Global burden of cancer and associated risk factors in 204 countries and territories, 1980\u20132021: a systematic analysis for the GBD 2021. J Hematol Oncol. 2024;17(1):119.","journal-title":"J Hematol Oncol"},{"key":"4284_CR2","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.immuni.2018.06.006","volume":"49","author":"J Li","year":"2018","unstructured":"Li J, Byrne KT, Yan F, Yamazoe T, Chen Z, Baslan T, et al. Tumor cell-intrinsic factors underlie heterogeneity of immune cell infiltration and response to immunotherapy. Immunity. 2018;49:178-193.e177.","journal-title":"Immunity"},{"issue":"1","key":"4284_CR3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41392-024-01848-7","volume":"9","author":"S Zhang","year":"2024","unstructured":"Zhang S, Xiao X, Yi Y, Wang X, Zhu L, Shen Y, et al. Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets. Signal Trans Target Ther. 2024;9(1):149.","journal-title":"Signal Trans Target Ther"},{"key":"4284_CR4","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1111\/cas.15497","volume":"113","author":"J Nagasaki","year":"2022","unstructured":"Nagasaki J, Ishino T, Togashi Y. Mechanisms of resistance to immune checkpoint inhibitors. Cancer Sci. 2022;113:3303\u201312.","journal-title":"Cancer Sci"},{"key":"4284_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12943-024-02212-7","volume":"24","author":"BH Alsaafeen","year":"2025","unstructured":"Alsaafeen BH, Ali BR, Elkord E. Resistance mechanisms to immune checkpoint inhibitors: updated insights. Mol Cancer. 2025;24:20\u201320.","journal-title":"Mol Cancer"},{"key":"4284_CR6","doi-asserted-by":"publisher","first-page":"218076","DOI":"10.1016\/j.canlet.2025.218076","volume":"634","author":"Q Chen","year":"2025","unstructured":"Chen Q, Jiang K, Bronze MS, Li M, Houchen CW, Zhang Y. Tumor microenvironment and macroenvironment: a new perspective on holistic oncology. Cancer Lett. 2025;634:218076\u2013218076.","journal-title":"Cancer Lett"},{"key":"4284_CR7","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41:374\u2013403.","journal-title":"Cancer Cell"},{"key":"4284_CR8","doi-asserted-by":"publisher","first-page":"100884","DOI":"10.1016\/j.xcrm.2022.100884","volume":"4","author":"C Xue","year":"2023","unstructured":"Xue C, Chu Q, Zheng Q, Yuan X, Su Y, Bao Z, et al. Current understanding of the intratumoral microbiome in various tumors. Cell Rep Med. 2023;4:100884\u2013100884.","journal-title":"Cell Rep Med"},{"issue":"1","key":"4284_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41392-023-01693-0","volume":"9","author":"Y Cao","year":"2023","unstructured":"Cao Y, Xia H, Tan X, Shi C, Ma Y, Meng D, et al. Intratumoural microbiota: a new frontier in cancer development and therapy. Signal Trans Target Ther. 2023;9(1):15.","journal-title":"Signal Trans Target Ther"},{"key":"4284_CR10","doi-asserted-by":"crossref","unstructured":"Nobels A, van Marcke C, Jordan BF, Van Hul M, Cani PD. The gut microbiome and cancer: from tumorigenesis to therapy. Nat Metab. 2025;7(5):895\u2013917.","DOI":"10.1038\/s42255-025-01287-w"},{"key":"4284_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-023-00442-x","volume":"12","author":"M Zhang","year":"2023","unstructured":"Zhang M, Liu J, Xia Q. Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target. Exp Hematol Oncol. 2023;12:84.","journal-title":"Exp Hematol Oncol"},{"key":"4284_CR12","doi-asserted-by":"crossref","unstructured":"Oliva M, Mulet-Margalef N, Ochoa-De-olza M, Napoli S, Mas J, Laquente B, et al. Tumor-associated microbiome: where do we stand? Int J Mol Sci. 2021;22:1446\u20131446.","DOI":"10.3390\/ijms22031446"},{"key":"4284_CR13","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.7150\/thno.54476","volume":"11","author":"SL Zhang","year":"2021","unstructured":"Zhang SL, Mao YQ, Zhang ZY, Li ZM, Kong CY, Chen HL, et al. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer. Theranostics. 2021;11:4155\u201370.","journal-title":"Theranostics"},{"key":"4284_CR14","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1126\/science.aaz7015","volume":"374","author":"CN Spencer","year":"2021","unstructured":"Spencer CN, McQuade JL, Gopalakrishnan V, McCulloch JA, Vetizou M, Cogdill AP, et al. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response. Science (New York, NY). 2021;374:1632\u20131632.","journal-title":"Science (New York, NY)"},{"key":"4284_CR15","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/s41551-021-00749-2","volume":"5","author":"K Han","year":"2021","unstructured":"Han K, Nam J, Xu J, Sun X, Huang X, Animasahun O, et al. Generation of systemic antitumour immunity via the in situ modulation of the gut microbiome by an orally administered inulin gel. Nat Biomed Eng. 2021;5:1377\u20131377.","journal-title":"Nat Biomed Eng"},{"key":"4284_CR16","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1158\/2159-8290.CD-25-0247","volume":"15","author":"KM Morder","year":"2025","unstructured":"Morder KM, Nguyen M, Wilfahrt DN, Dahmani ZL, Burr ABP, Xie B, et al. Sucralose consumption ablates cancer immunotherapy response through microbiome disruption. Cancer Discov. 2025;15:2278\u20132278.","journal-title":"Cancer Discov"},{"key":"4284_CR17","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1038\/s42255-024-01137-1","volume":"6","author":"SL Zhang","year":"2024","unstructured":"Zhang SL, Wang X, Cai QQ, Chen C, Zhang ZY, Xu YY, et al. Acarbose enhances the efficacy of immunotherapy against solid tumours by modulating the gut microbiota. Nat Metab. 2024;6:1991\u20132009.","journal-title":"Nat Metab"},{"key":"4284_CR18","doi-asserted-by":"crossref","unstructured":"Yang J, Wei H, Zhou YF, Szeto CH, Li CG, Lin YF, et al. High-fat diet promotes colorectal tumorigenesis through modulating gut microbiota and metabolites. Gastroenterology. 2022;162:135-+.","DOI":"10.1053\/j.gastro.2021.08.041"},{"key":"4284_CR19","doi-asserted-by":"publisher","first-page":"25638","DOI":"10.1021\/acs.jafc.4c06475","volume":"72","author":"H Li","year":"2024","unstructured":"Li H, Li C, Ren M, Zhang F, Cao L, Ren K, et al. Fasting-mimicking diet prevents pancreatic carcinogenesis via gut microbiota and metabolites. J Agric Food Chem. 2024;72:25638\u201347.","journal-title":"J Agric Food Chem"},{"key":"4284_CR20","doi-asserted-by":"publisher","first-page":"3890","DOI":"10.1158\/0008-5472.CAN-20-2983","volume":"81","author":"DR Soto-Pantoja","year":"2021","unstructured":"Soto-Pantoja DR, Gaber M, Arnone AA, Bronson SM, Cruz-Diaz N, Wilson AS, et al. Diet alters entero-mammary signaling to regulate the breast microbiome and tumorigenesis. Cancer Res. 2021;81:3890\u2013904.","journal-title":"Cancer Res"},{"key":"4284_CR21","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.aay9189","volume":"368","author":"D Nejman","year":"2020","unstructured":"Nejman D, Livyatan I, Fuks G, Gavert N, Zwang Y, Geller LT, et al. The human tumor microbiome is composed of tumor type\u2013specific intracellular bacteria. Science. 2020;368:973\u201380.","journal-title":"Science"},{"key":"4284_CR22","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s41586-022-05435-0","volume":"611","author":"JL Galeano Ni\u00f1o","year":"2022","unstructured":"Galeano Ni\u00f1o JL, Wu H, LaCourse KD, Kempchinsky AG, Baryiames A, Barber B, et al. Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer. Nature. 2022;611:810.","journal-title":"Nature"},{"key":"4284_CR23","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ccell.2025.09.010","volume":"44","author":"JL Galeano Ni\u00f1o","year":"2026","unstructured":"Galeano Ni\u00f1o JL, Ponath F, Ajisafe VA, Becker CR, Kempchinsky AG, Zepeda-Rivera MA, et al. Tumor-infiltrating bacteria disrupt cancer epithelial cell interactions and induce cell-cycle arrest. Cancer Cell. 2026;44:166-186.e116.","journal-title":"Cancer Cell"},{"key":"4284_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1301506","volume":"14","author":"J Wu","year":"2024","unstructured":"Wu J, Zhang P, Mei W, Zeng C. Intratumoral microbiota: implications for cancer onset, progression, and therapy. Front Immunol. 2024;14:1301506-1301506.","journal-title":"Front Immunol"},{"key":"4284_CR25","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.01146-25","author":"Q Fu","year":"2025","unstructured":"Fu Q, Zhao N, Li X, Li Y, Tian T, Gao L, et al. Effect of immune-related intratumoral microbiota and host gene expression on cancer prognosis. mSystems. 2025. https:\/\/doi.org\/10.1128\/msystems.01146-25.","journal-title":"mSystems"},{"key":"4284_CR26","doi-asserted-by":"publisher","first-page":"105708","DOI":"10.1016\/j.ebiom.2025.105708","volume":"115","author":"Y Situ","year":"2025","unstructured":"Situ Y, Zhang P, Zhang C, Jiang A, Zhang N, Zhu L, et al. The metabolic dialogue between intratumoural microbes and cancer: implications for immunotherapy. EBioMedicine. 2025;115:105708\u2013105708.","journal-title":"EBioMedicine"},{"key":"4284_CR27","first-page":"327","volume":"40","author":"J Ma","year":"2021","unstructured":"Ma J, Huang L, Hu D, Zeng S, Han Y, Shen H. The role of the tumor microbe microenvironment in the tumor immune microenvironment: bystander, activator, or inhibitor? J Exp Clin Cancer Res CR. 2021;40:327\u2013327.","journal-title":"J Exp Clin Cancer Res CR"},{"key":"4284_CR28","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.3390\/biomedicines13081929","volume":"13","author":"JH Kim","year":"2025","unstructured":"Kim JH, Seo H, Kim S, Rahim MA, Jo S, Barman I, et al. Association of intratumoral microbiota modulation with prostate cancer progression: a microbiome analysis of prostatic tissue. Biomedicines. 2025;13:1929\u20131929.","journal-title":"Biomedicines"},{"key":"4284_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1574511","volume":"15","author":"Y Guo","year":"2025","unstructured":"Guo Y, Xiao Y, Zhang C, Wang Y, Cao G, Tse KY, et al. The intratumoral microbiota heterogenicity is related to the prognosis and tumorigenesis of cervical cancer. Front Cell Infect Microbiol. 2025;15:1574511-1574511.","journal-title":"Front Cell Infect Microbiol"},{"key":"4284_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40987-3","volume":"14","author":"Y Li","year":"2023","unstructured":"Li Y, Xing S, Chen F, Li Q, Dou S, Huang Y, et al. Intracellular Fusobacterium nucleatum infection attenuates antitumor immunity in esophageal squamous cell carcinoma. Nat Commun. 2023;14:5788-5788.","journal-title":"Nat Commun"},{"key":"4284_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101753","volume":"5","author":"S Guo","year":"2024","unstructured":"Guo S, Xing S, Wu ZY, Chen F, Pan X, Li Q, et al. Leucine restriction ameliorates Fusobacterium nucleatum-driven malignant progression and radioresistance in nasopharyngeal carcinoma. Cell Rep Med. 2024;5:101753.","journal-title":"Cell Rep Med"},{"key":"4284_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16967-2","volume":"11","author":"L Parhi","year":"2020","unstructured":"Parhi L, Alon-Maimon T, Sol A, Nejman D, Shhadeh A, Fainsod-Levi T, et al. Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression. Nat Commun. 2020;11:3259-3259.","journal-title":"Nat Commun"},{"key":"4284_CR33","volume":"10","author":"T Li","year":"2024","unstructured":"Li T, Zhao Z, Peng M, Zhang L, Wang C, Luo F, et al. Multi-omics analysis reveals the interplay between intratumoral bacteria and glioma. mSystems. 2024;10:e00457-00424.","journal-title":"mSystems"},{"key":"4284_CR34","doi-asserted-by":"crossref","unstructured":"Liu J, Zhang Y. Intratumor microbiome in cancer progression: current developments, challenges and future trends. Biomarker Res. 2022;10(1):37.","DOI":"10.1186\/s40364-022-00381-5"},{"key":"4284_CR35","doi-asserted-by":"crossref","unstructured":"Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12:R60.","DOI":"10.1186\/gb-2011-12-6-r60"},{"key":"4284_CR36","doi-asserted-by":"crossref","unstructured":"Paulson JN, Stine OC, Bravo HC, Pop M. Differential abundance analysis for microbial marker-gene surveys. Nat Methods. 2013;10:1200-+.","DOI":"10.1038\/nmeth.2658"},{"key":"4284_CR37","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1101\/gr.126573.111","volume":"22","author":"AD Kostic","year":"2012","unstructured":"Kostic AD, Gevers D, Pedamallu CS, Michaud M, Duke F, Earl AM, et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 2012;22:292\u20138.","journal-title":"Genome Res"},{"key":"4284_CR38","doi-asserted-by":"crossref","unstructured":"Burns MB, Lynch J, Starr TK, Knights D, Blekhman R. Virulence genes are a signature of the microbiome in the colorectal tumor microenvironment. Genome Med. 2015;7:55.","DOI":"10.1186\/s13073-015-0177-8"},{"key":"4284_CR39","doi-asserted-by":"crossref","unstructured":"Dohlman AB, Mendoza DA, Ding SL, Gao M, Dressman H, Iliev ID, et al. The cancer microbiome atlas: a pan-cancer comparative analysis to distinguish tissue-resident microbiota from contaminants. Cell Host Microbe. 2021;29:281-+.","DOI":"10.1016\/j.chom.2020.12.001"},{"key":"4284_CR40","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","volume":"178","author":"E Riquelme","year":"2019","unstructured":"Riquelme E, Zhang Y, Zhang LL, Montiel M, Zoltan M, Dong WL, et al. Tumor microbiome diversity and composition influence pancreatic cancer outcomes. Cell. 2019;178:795.","journal-title":"Cell"},{"key":"4284_CR41","doi-asserted-by":"crossref","unstructured":"Sims TT, El Alam MB, Karpinets T, Dorta-Estremera S, Hegde VL, Nookala S, et al. Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation. Commun Biol.\u00a02021;4:237.","DOI":"10.1038\/s42003-021-01741-x"},{"key":"4284_CR42","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.eururo.2020.04.044","volume":"78","author":"L Derosa","year":"2020","unstructured":"Derosa L, Routy B, Fidelle M, Iebba V, Alla L, Pasolli E, et al. Gut bacteria composition drives primary resistance to cancer immunotherapy in renal cell carcinoma patients. Eur Urol. 2020;78:195\u2013206.","journal-title":"Eur Urol"},{"key":"4284_CR43","doi-asserted-by":"crossref","unstructured":"Mao JZ, Wang DX, Long JY, Yang X, Lin JZ, Song YW, et al. Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancers. J Immunother Cancer. 2021;9:e003334.\u00a0","DOI":"10.1136\/jitc-2021-003334"},{"key":"4284_CR44","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","volume":"359","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science. 2018;359:97\u2013103.","journal-title":"Science"},{"key":"4284_CR45","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daill\u00e8re R, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. 2018;359:91\u20137.","journal-title":"Science"},{"key":"4284_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1565661","volume":"15","author":"JH Kim","year":"2025","unstructured":"Kim JH, Kim B, Lee J, Kim J, Kwak JM, Lee S. Gut microbiome with RAS mutation and chemotherapy response in patients with advanced or metastatic colorectal cancer: a pilot, exploratory study. Front Oncol. 2025;15:1565661.","journal-title":"Front Oncol"},{"key":"4284_CR47","doi-asserted-by":"crossref","unstructured":"Nearing JT, Douglas GM, Hayes M, MacDonald J, Desai D, Allward N, et al. Microbiome differential abundance methods produce different results across 38 datasets. Nat Commun. 2022;13:342.","DOI":"10.1038\/s41467-022-28034-z"},{"key":"4284_CR48","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.1158\/0008-5472.CAN-24-3629","volume":"85","author":"MH Chia","year":"2025","unstructured":"Chia MH, Pop MH, Salzberg SL, Nagarajan N. Challenges and opportunities in analyzing cancer-associated microbiomes. Cancer Res. 2025;85:3584\u201395.","journal-title":"Cancer Res"},{"key":"4284_CR49","first-page":"453","volume":"29","author":"J Yoo","year":"2022","unstructured":"Yoo J, Sun ZQ, Greenacre M, Ma Q, Chung DJ, Kim YM. A guideline for the statistical analysis of compositional data in immunology. Commun Stat Appl Methods. 2022;29:453\u201369.","journal-title":"Commun Stat Appl Methods"},{"key":"4284_CR50","doi-asserted-by":"crossref","unstructured":"Friedman J, Alm EJ. Inferring correlation networks from genomic survey data. PLoS Comput Biol. 2012;8:e1002687.","DOI":"10.1371\/journal.pcbi.1002687"},{"key":"4284_CR51","doi-asserted-by":"crossref","unstructured":"Faust K, Sathirapongsasuti JF, Izard J, Segata N, Gevers D, Raes J, et al. Microbial co-occurrence relationships in the human microbiome. PLoS Comput Biol. 2012;8:e1002606.\u00a0","DOI":"10.1371\/journal.pcbi.1002606"},{"key":"4284_CR52","doi-asserted-by":"crossref","unstructured":"Kurtz ZD, M\u00fcller CL, Miraldi ER, Littman DR, Blaser MJ, Bonneau RA. Sparse and compositionally robust inference of microbial ecological networks. PLoS Comput Biol. 2015;11:e1004226.\u00a0","DOI":"10.1371\/journal.pcbi.1004226"},{"key":"4284_CR53","doi-asserted-by":"crossref","unstructured":"Uriarte-Navarrete I, Hern\u00e1ndez-Lemus E, de Anda-J\u00e1uregui G. Gene-microbiome co-expression networks in colon cancer. Front Genet. 2021;12:617505.\u00a0","DOI":"10.3389\/fgene.2021.617505"},{"key":"4284_CR54","doi-asserted-by":"crossref","unstructured":"Park CH, Lee JG, Lee AR, Eun CS, Han DS. Network construction of gastric microbiome and organization of microbial modules associated with gastric carcinogenesis. Sci Rep. 2019;9:12444.\u00a0","DOI":"10.1038\/s41598-019-48925-4"},{"key":"4284_CR55","doi-asserted-by":"crossref","unstructured":"Loftus M, Hassouneh SA, Yooseph S. Bacterial community structure alterations within the colorectal cancer gut microbiome. BMC Microbiol. 2021;21:98.","DOI":"10.1186\/s12866-021-02153-x"},{"key":"4284_CR56","doi-asserted-by":"crossref","unstructured":"Appiah EM, Yakubu B, Salifu SP. Comprehensive microbial network analysis of gastric microbiome reveal key species affecting gastric carcinogenesis. Microbe. 2023;1:100009.","DOI":"10.1016\/j.microb.2023.100009"},{"key":"4284_CR57","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s43588-022-00247-8","volume":"2","author":"LW Xiao","year":"2022","unstructured":"Xiao LW, Zhang FY, Zhao FQ. Large-scale microbiome data integration enables robust biomarker identification. Nat Comput Sci. 2022;2:307\u201316.","journal-title":"Nat Comput Sci"},{"key":"4284_CR58","doi-asserted-by":"crossref","unstructured":"He BS, Ma YY, Wang K, Bing PP, Ji L, Tian G, et al. Microbiome-transcriptome-histology triad enhances survival risk stratification in multiple cancers. Comput Biol Chem. 2026;120:108703.\u00a0","DOI":"10.1016\/j.compbiolchem.2025.108703"},{"key":"4284_CR59","doi-asserted-by":"crossref","unstructured":"Zhang HH, Xiong XH, Cheng MY, Ji L, Ning K. Deep learning enabled integration of tumor microenvironment microbial profiles and host gene expressions for interpretable survival subtyping in diverse types of cancers. mSystems. 2024;9:e01395.\u00a0","DOI":"10.1128\/msystems.01395-24"},{"key":"4284_CR60","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1089\/cmb.2024.0884","volume":"32","author":"XY Shi","year":"2025","unstructured":"Shi XY, Zhu FF, Min WW. VTrans: a VAE-based pre-trained transformer method for microbiome data analysis. J Comput Biol. 2025;32:850\u201364.","journal-title":"J Comput Biol"},{"key":"4284_CR61","doi-asserted-by":"crossref","unstructured":"Yang M, Yang HD, Ji L, Hu X, Tian G, Wang B, et al. A multi-omics machine learning framework in predicting the survival of colorectal cancer patients. Comput Biol Med. 2022;146:105516.\u00a0","DOI":"10.1016\/j.compbiomed.2022.105516"},{"key":"4284_CR62","doi-asserted-by":"crossref","unstructured":"Lee SJ, Rho M. Multimodal deep learning applied to classify healthy and disease states of human microbiome. Sci Rep. 2022;12:824.","DOI":"10.1038\/s41598-022-04773-3"},{"key":"4284_CR63","doi-asserted-by":"crossref","unstructured":"Salter SJ, Cox MJ, Turek EM, Calus ST, Cookson WO, Moffatt MF, et al. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol. 2014;12:87.\u00a0","DOI":"10.1186\/s12915-014-0087-z"},{"key":"4284_CR64","doi-asserted-by":"crossref","unstructured":"Sinha R, Abu-Ali G, Vogtmann E, Fodor AA, Ren BY, Amir A, et al. Assessment of variation in microbial community amplicon sequencing by the Microbiome Quality Control (MBQC) project consortium. Nat Biotechnol. 2017;35:1077-+.","DOI":"10.1038\/nbt.3981"},{"key":"4284_CR65","doi-asserted-by":"crossref","unstructured":"Costea PI, Zeller G, Sunagawa S, Pelletier E, Alberti A, Levenez F, et al. Towards standards for human fecal sample processing in metagenomic studies. Nat Biotechnol. 2017;35:1069-+.","DOI":"10.1038\/nbt.3960"},{"key":"4284_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-12037-3","volume":"12","author":"N Szostak","year":"2022","unstructured":"Szostak N, Szymanek A, Havranek J, Tomela K, Rakoczy M, Samelak-Czajka A, et al. The standardisation of the approach to metagenomic human gut analysis: from sample collection to microbiome profiling. Sci Rep. 2022;12:8470.","journal-title":"Sci Rep"},{"key":"4284_CR67","doi-asserted-by":"crossref","unstructured":"Gihawi A, Ge Y, Lu J, Puiu D, Xu A, Cooper CS, et al. Major data analysis errors invalidate cancer microbiome findings. MBio. 2023;14:e01607.","DOI":"10.1128\/mbio.01607-23"},{"key":"4284_CR68","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.tim.2023.01.011","volume":"31","author":"Q Wang","year":"2023","unstructured":"Wang Q, Liu ZQ, Ma AJ, Li ZH, Liu BQ, Ma Q. Computational methods and challenges in analyzing intratumoral microbiome data. Trends Microbiol. 2023;31:707\u201322.","journal-title":"Trends Microbiol"},{"key":"4284_CR69","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1038\/s41592-025-02807-y","volume":"22","author":"YJ Li","year":"2025","unstructured":"Li YJ, Ma AJ, Johnson E, Eng C, De S, Jiang SZ, et al. The new microbiome on the block: challenges and opportunities of using human tumor sequencing data to study microbes. Nat Methods. 2025;22:1788\u201399.","journal-title":"Nat Methods"},{"key":"4284_CR70","doi-asserted-by":"crossref","unstructured":"Johnson JS, Spakowicz DJ, Hong BY, Petersen LM, Demkowicz P, Chen L, et al. Evaluation of 16S rRNA gene sequencing for species and strain-level microbiome analysis. Nat Commun. 2019;10(1):5029.","DOI":"10.1038\/s41467-019-13036-1"},{"key":"4284_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-73403-7","volume":"10","author":"SP Walker","year":"2020","unstructured":"Walker SP, Barrett M, Hogan G, Flores Bueso Y, Claesson MJ, Tangney M. Non-specific amplification of human DNA is a major challenge for 16S rRNA gene sequence analysis. Sci Rep. 2020;10:16356.","journal-title":"Sci Rep"},{"key":"4284_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-024-10621-7","volume":"25","author":"D Bars-Cortina","year":"2024","unstructured":"Bars-Cortina D, Ramon E, Rius-Sansalvador B, Guin\u00f3 E, Garcia-Serrano A, Mach N, et al. Comparison between 16S rRNA and shotgun sequencing in colorectal cancer, advanced colorectal lesions, and healthy human gut microbiota. BMC Genomics. 2024;25:730-730.","journal-title":"BMC Genomics"},{"key":"4284_CR73","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00399-24","volume":"9","author":"H Zhang","year":"2024","unstructured":"Zhang H, Wang X, Chen A, Li S, Tao R, Chen K, et al. Comparison of the full-length sequence and sub-regions of 16S rRNA gene for skin microbiome profiling. mSystems. 2024;9:e00399-24.","journal-title":"mSystems"},{"key":"4284_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241813786","volume":"24","author":"L Aitmanait\u0117","year":"2023","unstructured":"Aitmanait\u0117 L, \u0160irmonaitis K, Russo G. Microbiomes, their function, and cancer: how metatranscriptomics can close the knowledge gap. Int J Mol Sci. 2023;24:13786.","journal-title":"Int J Mol Sci"},{"key":"4284_CR75","doi-asserted-by":"crossref","unstructured":"Sun Z, Ning Z, Figeys D. The landscape and perspectives of the human gut metaproteomics. Mol Cell Proteomics. 2024;23:100763.\u00a0","DOI":"10.1016\/j.mcpro.2024.100763"},{"key":"4284_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1337368","volume":"15","author":"N Chakraborty","year":"2024","unstructured":"Chakraborty N. Metabolites: a converging node of host and microbe to explain meta-organism. Front Microbiol. 2024;15:1337368.","journal-title":"Front Microbiol"},{"key":"4284_CR77","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/978-1-4939-2377-9_13","volume":"1277","author":"AH Emwas","year":"2015","unstructured":"Emwas AH. The strengths and weaknesses of NMR spectroscopy and mass spectrometry with particular focus on metabolomics research. Methods Mol Biol. 2015;1277:161\u201393.","journal-title":"Methods Mol Biol"},{"key":"4284_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.866463","volume":"12","author":"K Rebrosova","year":"2022","unstructured":"Rebrosova K, Samek O, Kizovsky M, Bernatova S, Hola V, Ruzicka F. Raman spectroscopy-A novel method for identification and characterization of microbes on a single-cell level in clinical settings. Front Cell Infect Microbiol. 2022;12:866463.","journal-title":"Front Cell Infect Microbiol"},{"key":"4284_CR79","doi-asserted-by":"crossref","unstructured":"Galeano Ni\u00f1o JL, Wu H, LaCourse KD, Srinivasan H, Fitzgibbon M, Minot SS, et al. INVADEseq to identify cell-adherent or invasive bacteria and the associated host transcriptome at single-cell-level resolution. Nat Prot. 2023;18(11):3355\u20133389.","DOI":"10.1038\/s41596-023-00888-7"},{"key":"4284_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1559870","volume":"15","author":"M Meyers","year":"2025","unstructured":"Meyers M, Stoffels CBA, Frache G, Letellier E, Feucherolles M. Microbiome in cancer metastasis: biological insights and emerging spatial omics methods. Front Cell Infect Microbiol. 2025;15:1559870-1559870.","journal-title":"Front Cell Infect Microbiol"},{"key":"4284_CR81","doi-asserted-by":"crossref","unstructured":"Chen W, Qiu M, Paizs P, Sadowski M, Ramonaite T, Zborovsky L, et al. Universal, untargeted detection of bacteria in tissues using metabolomics workflows. Nat Commun 2024. 2025;16(1):165.","DOI":"10.1038\/s41467-024-55457-7"},{"key":"4284_CR82","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adj7402","volume":"10","author":"W Robinson","year":"2024","unstructured":"Robinson W, Stone JK, Schischlik F, Gasmi B, Kelly MC, Seibert C, et al. Identification of intracellular bacteria from multiple single-cell RNA-seq platforms using CSI-Microbes. Sci Adv. 2024;10:7402-7402.","journal-title":"Sci Adv"},{"key":"4284_CR83","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.ccell.2022.09.009","volume":"40","author":"B Ghaddar","year":"2022","unstructured":"Ghaddar B, Biswas A, Harris C, Omary MB, Carpizo DR, Blaser MJ, et al. Tumor microbiome links cellular programs and immunity in pancreatic cancer. Cancer Cell. 2022;40:1240-1253.e1245.","journal-title":"Cancer Cell"},{"key":"4284_CR84","doi-asserted-by":"publisher","DOI":"10.1172\/JCI154944","volume":"132","author":"CR Wensel","year":"2022","unstructured":"Wensel CR, Pluznick JL, Salzberg SL, Sears CL. Next-generation sequencing: insights to advance clinical investigations of the microbiome. J Clin Invest. 2022;132:e154944-e154944.","journal-title":"J Clin Invest"},{"key":"4284_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00459","volume":"7","author":"J Jovel","year":"2016","unstructured":"Jovel J, Patterson J, Wang W, Hotte N, O\u2019Keefe S, Mitchel T, et al. Characterization of the gut microbiome using 16S or shotgun metagenomics. Front Microbiol. 2016;7:180723-180723.","journal-title":"Front Microbiol"},{"key":"4284_CR86","first-page":"37","volume":"34","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Thompson KN, Branck T, Yan Y, Nguyen LH, Franzosa EA, et al. Metatranscriptomics for the human microbiome and microbial community functional profiling. Annu Rev Biomed Data Sci. 2025;34:37\u201337.","journal-title":"Annu Rev Biomed Data Sci"},{"key":"4284_CR87","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1093\/bib\/bby012","volume":"19","author":"SY Niu","year":"2018","unstructured":"Niu SY, Yang J, McDermaid A, Zhao J, Kang Y, Ma Q. Bioinformatics tools for quantitative and functional metagenome and metatranscriptome data analysis in microbes. Brief Bioinform. 2018;19:360.","journal-title":"Brief Bioinform"},{"key":"4284_CR88","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/pros.24276","volume":"82","author":"A Zarei","year":"2022","unstructured":"Zarei A, Javid H, Sanjarian S, Senemar S, Zarei H. Metagenomics studies for the diagnosis and treatment of prostate cancer. Prostate. 2022;82:289\u201397.","journal-title":"Prostate"},{"key":"4284_CR89","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1038\/s41591-019-0663-4","volume":"25","author":"AM Thomas","year":"2019","unstructured":"Thomas AM, Manghi P, Asnicar F, Pasolli E, Armanini F, Zolfo M, et al. Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation (vol 25, pg 667, 2019). Nat Med. 2019;25:1948\u20131948.","journal-title":"Nat Med"},{"key":"4284_CR90","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-019-0406-6","volume":"25","author":"J Wirbel","year":"2019","unstructured":"Wirbel J, Pyl PT, Kartal E, Zych K, Kashani A, Milanese A, et al. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer. Nat Med. 2019;25:679\u2013679.","journal-title":"Nat Med"},{"key":"4284_CR91","doi-asserted-by":"publisher","DOI":"10.1111\/1751-7915.70115","volume":"18","author":"Y Wang","year":"2025","unstructured":"Wang Y, Qiu X, Chu A, Chen J, Wang L, Sun X, et al. Advances in 16S rRNA-based microbial biomarkers for gastric cancer diagnosis and prognosis. Microb Biotechnol. 2025;18:e70115.","journal-title":"Microb Biotechnol"},{"key":"4284_CR92","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s40425-019-0574-4","volume":"7","author":"J Fessler","year":"2019","unstructured":"Fessler J, Matson V, Gajewski TF. Exploring the emerging role of the microbiome in cancer immunotherapy. J Immunother Cancer. 2019;7:108\u2013108.","journal-title":"J Immunother Cancer"},{"key":"4284_CR93","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s43556-025-00248-9","volume":"6","author":"S Zhang","year":"2025","unstructured":"Zhang S, Huang J, Jiang Z, Tong H, Ma X, Liu Y. Tumor microbiome: roles in tumor initiation, progression, and therapy. Mol Biomed. 2025;6:9\u20139.","journal-title":"Mol Biomed"},{"key":"4284_CR94","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.3390\/ijms20174145","volume":"20","author":"R Aarnoutse","year":"2019","unstructured":"Aarnoutse R, Ziemons J, Penders J, Rensen SS, De Vos-Geelen J, Smidt ML. The clinical link between human intestinal microbiota and systemic cancer therapy. Int J Mol Sci. 2019;20:4145\u20134145.","journal-title":"Int J Mol Sci"},{"key":"4284_CR95","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/ismej.2008.108","volume":"3","author":"NC Verberkmoes","year":"2009","unstructured":"Verberkmoes NC, Russell AL, Shah M, Godzik A, Rosenquist M, Halfvarson J, et al. Shotgun metaproteomics of the human distal gut microbiota. ISME J. 2009;3:179\u201389.","journal-title":"ISME J"},{"key":"4284_CR96","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/14789450.2023.2215440","volume":"20","author":"M Wolf","year":"2023","unstructured":"Wolf M, Schallert K, Knipper L, Sickmann A, Sczyrba A, Benndorf D, et al. Advances in the clinical use of metaproteomics. Expert Rev Proteomics. 2023;20:71\u201386.","journal-title":"Expert Rev Proteomics"},{"key":"4284_CR97","doi-asserted-by":"crossref","unstructured":"Xiao M, Yang J, Feng Y, Zhu Y, Chai X, Wang Y. Metaproteomic strategies and applications for gut microbial research. Appl Microbiol Biotechnol. 2017;101(8):3077\u20133088.","DOI":"10.1007\/s00253-017-8215-7"},{"key":"4284_CR98","doi-asserted-by":"publisher","first-page":"105455","DOI":"10.1016\/j.jprot.2025.105455","volume":"318","author":"M Wolf","year":"2025","unstructured":"Wolf M, Lange J, Benndorf D, Welz L, Nikolaus S, Siever LK, et al. Fecal metaproteomics enables functional characterization of remission in patients with inflammatory bowel disease. J Proteomics. 2025;318:105455\u2013105455.","journal-title":"J Proteomics"},{"key":"4284_CR99","doi-asserted-by":"crossref","unstructured":"Xian F, Brenek M, Krisp C, Urbauer E, Ravi Kumar RK, Aguanno D, et al. Ultra-sensitive metaproteomics redefines the dark metaproteome, uncovering host\u2013microbiome interactions and drug targets in intestinal diseases. Nat Commun. 2025;16(1):6644.","DOI":"10.1038\/s41467-025-61977-7"},{"key":"4284_CR100","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.3390\/cells11081340","volume":"11","author":"C Henry","year":"2022","unstructured":"Henry C, Bassignani A, Berland M, Langella O, Sokol H, Juste C. Modern metaproteomics: a unique tool to characterize the active microbiome in health and diseases, and pave the road towards new biomarkers\u2014example of Crohn\u2019s disease and ulcerative colitis flare-ups. Cells. 2022;11:1340\u20131340.","journal-title":"Cells"},{"key":"4284_CR101","first-page":"9781578","volume":"2022","author":"X Jiang","year":"2022","unstructured":"Jiang X, Zhang Y, Wang H, Wang Z, Hu S, Cao C, et al. In-depth metaproteomics analysis of oral microbiome for lung cancer. Research (Wash D C). 2022;2022:9781578.","journal-title":"Research (Wash D C)"},{"key":"4284_CR102","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-020-0123-4","volume":"6","author":"S Long","year":"2020","unstructured":"Long S, Yang Y, Shen C, Wang Y, Deng A, Qin Q, et al. Metaproteomics characterizes human gut microbiome function in colorectal cancer. NPJ Biofilms Microbiomes. 2020;6:14.","journal-title":"NPJ Biofilms Microbiomes"},{"key":"4284_CR103","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-023-01730-8","volume":"12","author":"J Chen","year":"2024","unstructured":"Chen J, Sun Y, Li J, Lyu M, Yuan L, Sun J, et al. In-depth metaproteomics analysis of tongue coating for gastric cancer: a multicenter diagnostic research study. Microbiome. 2024;12:6.","journal-title":"Microbiome"},{"key":"4284_CR104","doi-asserted-by":"crossref","unstructured":"Sobhy EE, Ezzeldin S, Karam A, Galal A, Mokhtar A, Anwar W, et al. Functional microbial shifts and host-microbiome crosstalk in colorectal cancer: insights from a metaproteomic approach. BMC Microbiol. 2026;26:294.\u00a0","DOI":"10.1186\/s12866-026-04807-0"},{"key":"4284_CR105","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1007\/s00248-020-01596-5","volume":"82","author":"MG Torralba","year":"2021","unstructured":"Torralba MG, Aleti G, Li W, Moncera KJ, Lin YH, Yu Y, et al. Oral microbial species and virulence factors associated with oral squamous cell carcinoma. Microb Ecol. 2021;82:1030\u201346.","journal-title":"Microb Ecol"},{"key":"4284_CR106","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-023-02991-x","volume":"23","author":"RH Khattab","year":"2023","unstructured":"Khattab RH, Abo-Hammam RH, Salah M, Hanora AM, Shabayek S, Zakeer S. Multi-omics analysis of fecal samples in colorectal cancer Egyptians patients: a pilot study. BMC Microbiol. 2023;23:238.","journal-title":"BMC Microbiol"},{"key":"4284_CR107","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.869523","volume":"13","author":"A Tanca","year":"2022","unstructured":"Tanca A, Abbondio M, Fiorito G, Pira G, Sau R, Manca A, et al. Metaproteomic profile of the colonic luminal microbiota from patients with colon cancer. Front Microbiol. 2022;13:869523.","journal-title":"Front Microbiol"},{"key":"4284_CR108","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-97984-3","volume":"15","author":"J Canderan","year":"2025","unstructured":"Canderan J, Ye Y. Identification of microbial species and proteins associated with colorectal cancer by reanalyzing CPTAC proteomic datasets. Sci Rep. 2025;15:13926.","journal-title":"Sci Rep"},{"key":"4284_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbapap.2021.140659","volume":"1869","author":"DC Granato","year":"2021","unstructured":"Granato DC, Neves LX, Trino LD, Carnielli CM, Lopes AFB, Yokoo S, et al. Meta-omics analysis indicates the saliva microbiome and its proteins associated with the prognosis of oral cancer patients. Biochim Biophys Acta Proteins Proteom. 2021;1869:140659.","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"key":"4284_CR110","doi-asserted-by":"crossref","unstructured":"Ruan W, Engevik MA, Spinler JK, Versalovic J. Healthy human gastrointestinal microbiome: composition and function after a decade of exploration. Digest Dis Sci. 2020;65(3):695\u2013705.","DOI":"10.1007\/s10620-020-06118-4"},{"key":"4284_CR111","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ymeth.2023.12.007","volume":"222","author":"J Roach","year":"2024","unstructured":"Roach J, Mital R, Haffner JJ, Colwell N, Coats R, Palacios HM, et al. Microbiome metabolite quantification methods enabling insights into human health and disease. Methods. 2024;222:81\u201399.","journal-title":"Methods"},{"key":"4284_CR112","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3390\/metabo12060488","volume":"12","author":"EP Resurreccion","year":"2022","unstructured":"Resurreccion EP, Fong KW. The integration of metabolomics with other omics: insights into understanding prostate cancer. Metabolites. 2022;12:488\u2013488.","journal-title":"Metabolites"},{"key":"4284_CR113","doi-asserted-by":"crossref","unstructured":"Vo DK, Trinh KTL. Emerging biomarkers in metabolomics: advancements in precision health and disease diagnosis. Int J Mol Sci. 2024;25:13190\u201313190.","DOI":"10.3390\/ijms252313190"},{"key":"4284_CR114","doi-asserted-by":"publisher","first-page":"D623","DOI":"10.1093\/nar\/gkaf1272","volume":"54","author":"R Kruger","year":"2026","unstructured":"Kruger R, Oler E, Saha S, Poelzer J, Han S, Punsalan MP, et al. MiMeDB 2.0: the human microbial metabolome database for 2026. Nucleic Acids Res. 2026;54:D623\u201334.","journal-title":"Nucleic Acids Res"},{"key":"4284_CR115","doi-asserted-by":"crossref","unstructured":"van Santen JA, Poynton EF, Iskakova D, McMann E, Alsup TA, Clark TN, et al. The Natural Products Atlas 2.0: a database of microbially-derived natural products. Nucleic Acids Res. 2022;50:D1317-D1323.","DOI":"10.1093\/nar\/gkab941"},{"key":"4284_CR116","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41587-019-0375-9","volume":"38","author":"M Wang","year":"2020","unstructured":"Wang M, Jarmusch AK, Vargas F, Aksenov AA, Gauglitz JM, Weldon K, et al. Mass spectrometry searches using MASST. Nat Biotechnol. 2020;38:23\u20136.","journal-title":"Nat Biotechnol"},{"key":"4284_CR117","volume":"10","author":"Q Yang","year":"2023","unstructured":"Yang Q, Wang B, Zheng Q, Li H, Meng X, Zhou F, et al. A review of gut microbiota-derived metabolites in tumor progression and cancer therapy. Adv Sci. 2023;10:2207366-2207366.","journal-title":"Adv Sci"},{"key":"4284_CR118","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3892\/ijo.2024.5661","volume":"65","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Han W, Feng Y, Wang Y, Sun T, Xu J. Microbial metabolites affect tumor progression, immunity and therapy prediction by reshaping the tumor microenvironment (review). Int J Oncol. 2024;65:73\u201373.","journal-title":"Int J Oncol"},{"key":"4284_CR119","doi-asserted-by":"crossref","unstructured":"Mafe AN, B\u00fcsselberg D. The effect of microbiome-derived metabolites in inflammation-related cancer prevention and treatment. Biomolecules. 2025;15:688\u2013688.","DOI":"10.3390\/biom15050688"},{"key":"4284_CR120","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1073\/pnas.1808950116","volume":"116","author":"C Sun","year":"2019","unstructured":"Sun C, Li T, Song X, Huang L, Zang Q, Xu J, et al. Spatially resolved metabolomics to discover tumor-associated metabolic alterations. Proc Natl Acad Sci U S A. 2019;116:52\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4284_CR121","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1016\/j.cell.2024.03.021","volume":"187","author":"TW Battaglia","year":"2024","unstructured":"Battaglia TW, Mimpen IL, Traets JJH, van Hoeck A, Zeverijn LJ, Geurts BS, et al. A pan-cancer analysis of the microbiome in metastatic cancer. Cell. 2024;187:2324-2335.e2319.","journal-title":"Cell"},{"key":"4284_CR122","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3390\/microorganisms13020467","volume":"13","author":"SK Rad","year":"2025","unstructured":"Rad SK, Yeo KKL, Wu F, Li R, Nourmohammadi S, Tomita Y, et al. A systematic review and meta-analysis of 16S rRNA and cancer microbiome atlas datasets to characterize microbiota signatures in normal breast, mastitis, and breast cancer. Microorganisms. 2025;13:467\u2013467.","journal-title":"Microorganisms"},{"key":"4284_CR123","doi-asserted-by":"crossref","unstructured":"Ge Y, Lu J, Puiu D, Revsine M, Salzberg SL. Comprehensive analysis of microbial content in whole-genome sequencing samples from The Cancer Genome Atlas project. Sci Transl Med. 2025;17:eads6335.\u00a0","DOI":"10.1126\/scitranslmed.ads6335"},{"key":"4284_CR124","doi-asserted-by":"crossref","unstructured":"Sepich-Poore GD, McDonald D, Kopylova E, Guccione C, Zhu Q, Austin G, et al. Robustness of cancer microbiome signals over a broad range of methodological variation. Oncogene. 2024;43(15):1127\u20131148.","DOI":"10.1038\/s41388-024-02974-w"},{"key":"4284_CR125","doi-asserted-by":"crossref","unstructured":"Duan T, Rosenbaum A, Chandra V, Tiraboschi L, Rescigno M, McAllister F, et al. Toward a consensus on the tumor microbiota: evidence, standards, and interpretation. Cancer Cell. 2026;0:696.","DOI":"10.1016\/j.ccell.2026.02.011"},{"key":"4284_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2026.04.015","author":"AB Dohlman","year":"2026","unstructured":"Dohlman AB, Mjelle R, Wood HM, Jiang K, Shumate A, Lee I, et al. Biodiversity and biogeography of the multi-kingdom cancer microbiome. Cell. 2026. https:\/\/doi.org\/10.1016\/j.cell.2026.04.015.","journal-title":"Cell"},{"key":"4284_CR127","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/cyto.a.24550","volume":"101","author":"Z Feng","year":"2022","unstructured":"Feng Z, Hu Y, Wang X, Li Y, Yu Y, He J, et al. In situ imaging for tumor microbiome interactions via imaging mass cytometry on single-cell level. Cytometry A. 2022;101:617\u201329.","journal-title":"Cytometry A"},{"key":"4284_CR128","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.73","volume":"2","author":"N Zhang","year":"2023","unstructured":"Zhang N, Kandalai S, Zhou X, Hossain F, Zheng Q. Applying multi\u2010omics toward tumor microbiome research. iMeta. 2023;2:e73.","journal-title":"iMeta"},{"key":"4284_CR129","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2297860","volume":"16","author":"A Chetty","year":"2024","unstructured":"Chetty A, Blekhman R. Multi-omic approaches for host-microbiome data integration. Gut Microbes. 2024;16:2297860-2297860.","journal-title":"Gut Microbes"},{"key":"4284_CR130","volume":"13","author":"PHG Sanches","year":"2024","unstructured":"Sanches PHG, de Melo NC, Porcari AM, de Carvalho LM. Integrating molecular perspectives: strategies for comprehensive multi-omics integrative data analysis and machine learning applications in transcriptomics, proteomics, and metabolomics. Biology (Basel). 2024;13:848.","journal-title":"Biology (Basel)"},{"key":"4284_CR131","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-024-01987-7","volume":"12","author":"L Liang","year":"2024","unstructured":"Liang L, Kong C, Li J, Liu G, Wei J, Wang G, et al. Distinct microbes, metabolites, and the host genome define the multi-omics profiles in right-sided and left-sided colon cancer. Microbiome. 2024;12:274-274.","journal-title":"Microbiome"},{"key":"4284_CR132","volume":"12","author":"J Li","year":"2024","unstructured":"Li J, Zhang Y, Cai Y, Yao P, Jia Y, Wei X, et al. Multi-omics analysis elucidates the relationship between intratumor microbiome and host immune heterogeneity in breast cancer. Microbiol Spectr. 2024;12:e04104-04123.","journal-title":"Microbiol Spectr"},{"key":"4284_CR133","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00805-24","volume":"10","author":"Y Qin","year":"2025","unstructured":"Qin Y, Wang Q, Lin Q, Liu F, Pan X, Wei C, et al. Multi-omics analysis reveals associations between gut microbiota and host transcriptome in colon cancer patients. mSystems. 2025;10:e00805-24.","journal-title":"mSystems"},{"key":"4284_CR134","doi-asserted-by":"crossref","unstructured":"Huang J, Yang Q, Zeng L, Deng K. Multi-omics network toxicology reveals the role of benzo[a]pyrene in ovarian cancer: integrating gut microbiota dynamics and Mendelian randomization. Ecotoxicol Environ Saf. 2025;302:118601.","DOI":"10.1016\/j.ecoenv.2025.118601"},{"key":"4284_CR135","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1186\/s12967-025-06662-5","volume":"23","author":"MM Omran","year":"2025","unstructured":"Omran MM, Emam M, Gamaleldin M, Abushady AM, Elattar MA, El-Hadidi M. Comparative analysis of statistical and deep learning-based multi-omics integration for breast cancer subtype classification. J Transl Med. 2025;23:709\u2013709.","journal-title":"J Transl Med"},{"key":"4284_CR136","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-22350-2","volume":"15","author":"MS Kwak","year":"2025","unstructured":"Kwak MS, Cha JM, Kim CW, Won KY, Hwang CI. Integrative multi-omics deciphers the potential mechanism and microbial biomarkers for lymph node metastasis in colorectal cancer. Sci Rep. 2025;15:38611.","journal-title":"Sci Rep"},{"key":"4284_CR137","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1186\/s12967-024-05485-0","volume":"22","author":"Y Sun","year":"2024","unstructured":"Sun Y, Gan Z, Wang X, Liu J, Zhong W, Zhang Z, et al. Integrative metagenomic, transcriptomic, and proteomic analysis reveal the microbiota-host interplay in early-stage lung adenocarcinoma among non-smokers. J Transl Med. 2024;22:652\u2013652.","journal-title":"J Transl Med"},{"key":"4284_CR138","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/B978-0-443-13595-8.00010-6","volume-title":"Multi-omics technology in human health and diseases: genomics, epigenomics, transcriptomics, proteomics, metabolomics, radiomics, multi-omics","author":"R Jan","year":"2025","unstructured":"Jan R, Hussain A, Assad A, Khurshid S, Macha MA. Challenges with multi-omics data integration. In: Multi-omics technology in human health and diseases: genomics, epigenomics, transcriptomics, proteomics, metabolomics, radiomics, multi-omics. 2025. p. 223\u201342."},{"key":"4284_CR139","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.csbj.2022.11.050","volume":"21","author":"E Athieniti","year":"2023","unstructured":"Athieniti E, Spyrou GM. A guide to multi-omics data collection and integration for translational medicine. Comput Struct Biotechnol J. 2023;21:134\u201349.","journal-title":"Comput Struct Biotechnol J"},{"key":"4284_CR140","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s12551-023-01092-3","volume":"16","author":"X Wang","year":"2023","unstructured":"Wang X, Wu X, Hong N, Jin W. Progress in single-cell multimodal sequencing and multi-omics data integration. Biophys Rev. 2023;16:13\u201313.","journal-title":"Biophys Rev"},{"key":"4284_CR141","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaf355","volume":"26","author":"AR Bai\u00e3o","year":"2025","unstructured":"Bai\u00e3o AR, Cai Z, Poulos RC, Robinson PJ, Reddel RR, Zhong Q, et al. A technical review of multi-omics data integration methods: from classical statistical to deep generative approaches. Brief Bioinform. 2025;26:bbaf355-bbaf355.","journal-title":"Brief Bioinform"},{"key":"4284_CR142","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30:2114\u201320.","journal-title":"Bioinformatics"},{"key":"4284_CR143","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14806\/ej.17.1.200","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 2011;17:10\u20132.","journal-title":"EMBnet J"},{"key":"4284_CR144","unstructured":"Andrews S. FastQC: a quality control tool for high throughput sequence data. Babraham Bioinformatics; 2010. Available from: http:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/"},{"key":"4284_CR145","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJ, Holmes SP. DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13:581\u20133.","journal-title":"Nat Methods"},{"key":"4284_CR146","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/s41592-023-01940-w","volume":"20","author":"A Chklovski","year":"2023","unstructured":"Chklovski A, Parks DH, Woodcroft BJ, Tyson GW. CheckM2: a rapid, scalable and accurate tool for assessing microbial genome quality using machine learning. Nat Methods. 2023;20:1203\u201312.","journal-title":"Nat Methods"},{"key":"4284_CR147","doi-asserted-by":"crossref","unstructured":"Wei G, Wu N, Zhao K, Yang S, Wang L, Liu Y. DeepCheck: multitask learning aids in assessing microbial genome quality. Brief Bioinform. 2024;25:bbae539.","DOI":"10.1093\/bib\/bbae539"},{"key":"4284_CR148","doi-asserted-by":"crossref","unstructured":"Zou B, Wang J, Ding Y, Zhang Z, Huang Y, Fang X, et al. Deepurify: a multi-modal deep language model to remove contamination from metagenome-assembled genomes. bioRxiv. 2023:2023.2009.2027.559668.","DOI":"10.1101\/2023.09.27.559668"},{"key":"4284_CR149","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13059-021-02294-2","volume":"22","author":"S Albrecht","year":"2021","unstructured":"Albrecht S, Sprang M, Andrade-Navarro MA, Fontaine JF. SeqQscorer: automated quality control of next-generation sequencing data using machine learning. Genome Biol. 2021;22:75.","journal-title":"Genome Biol"},{"key":"4284_CR150","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1181911","volume":"11","author":"C Price","year":"2023","unstructured":"Price C, Russell JA. AMAnD: an automated metagenome anomaly detection methodology utilizing DeepSVDD neural networks. Front Public Health. 2023;11:1181911.","journal-title":"Front Public Health"},{"key":"4284_CR151","doi-asserted-by":"crossref","unstructured":"Peleg O, Raytan M, Borenstein E. KADAIF: an anomaly detection method for complex microbiome data. Bioinformatics. 2025;41:btaf520.\u00a0","DOI":"10.1093\/bioinformatics\/btaf520"},{"key":"4284_CR152","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.tim.2018.11.003","volume":"27","author":"R Eisenhofer","year":"2019","unstructured":"Eisenhofer R, Minich JJ, Marotz C, Cooper A, Knight R, Weyrich LS. Contamination in low microbial biomass microbiome studies: issues and recommendations. Trends Microbiol. 2019;27:105\u201317.","journal-title":"Trends Microbiol"},{"key":"4284_CR153","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1038\/s41564-025-02035-2","volume":"10","author":"N Fierer","year":"2025","unstructured":"Fierer N, Leung PM, Lappan R, Eisenhofer R, Ricci F, Holland SI, et al. Guidelines for preventing and reporting contamination in low-biomass microbiome studies. Nat Microbiol. 2025;10:1570\u201380.","journal-title":"Nat Microbiol"},{"key":"4284_CR154","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1016\/j.cell.2022.09.015","volume":"185","author":"AB Dohlman","year":"2022","unstructured":"Dohlman AB, Klug J, Mesko M, Gao IH, Lipkin SM, Shen X, et al. A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumors. Cell. 2022;185:3807-3822 e3812.","journal-title":"Cell"},{"key":"4284_CR155","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1038\/s41587-023-01696-w","volume":"41","author":"GI Austin","year":"2023","unstructured":"Austin GI, Park H, Meydan Y, Seeram D, Sezin T, Lou YC, et al. Contamination source modeling with SCRuB improves cancer phenotype prediction from microbiome data. Nat Biotechnol. 2023;41:1820\u20138.","journal-title":"Nat Biotechnol"},{"key":"4284_CR156","doi-asserted-by":"crossref","unstructured":"Goulet L, O\u00f1ate FP, Famechon A, Quinquis B, Belda E, Prifti E, et al. CroCoDeEL: accurate control-free detection of cross-sample contamination in metagenomic data. bioRxiv. 2025:2025.2001. 2015.633153.","DOI":"10.1101\/2025.01.15.633153"},{"key":"4284_CR157","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:357\u20139.","journal-title":"Nat Methods"},{"key":"4284_CR158","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25:1754\u201360.","journal-title":"Bioinformatics"},{"key":"4284_CR159","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1891-0","volume":"20","author":"DE Wood","year":"2019","unstructured":"Wood DE, Lu J, Langmead B. Improved metagenomic analysis with Kraken 2. Genome Biol. 2019;20:257.","journal-title":"Genome Biol"},{"key":"4284_CR160","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.03349","volume":"9","author":"J Tamames","year":"2018","unstructured":"Tamames J, Puente-Sanchez F. SqueezeMeta, a highly portable, fully automatic metagenomic analysis pipeline. Front Microbiol. 2018;9:3349.","journal-title":"Front Microbiol"},{"key":"4284_CR161","doi-asserted-by":"crossref","unstructured":"Herazo-Alvarez J, Mora M, Cuadros-Orellana S, Vilches-Ponce K, Hernandez-Garcia R. A review of neural networks for metagenomic binning. Brief Bioinform. 2025;26:bbaf065.\u00a0","DOI":"10.1093\/bib\/bbaf065"},{"key":"4284_CR162","doi-asserted-by":"publisher","DOI":"10.1093\/nargab\/lqaa009","volume":"2","author":"Q Liang","year":"2020","unstructured":"Liang Q, Bible PW, Liu Y, Zou B, Wei L. DeepMicrobes: taxonomic classification for metagenomics with deep learning. NAR Genom Bioinform. 2020;2:lqaa009.","journal-title":"NAR Genom Bioinform"},{"key":"4284_CR163","doi-asserted-by":"publisher","DOI":"10.1093\/nargab\/lqad082","volume":"5","author":"A Wichmann","year":"2023","unstructured":"Wichmann A, Buschong E, Muller A, Junger D, Hildebrandt A, Hankeln T, et al. Metatransformer: deep metagenomic sequencing read classification using self-attention models. NAR Genom Bioinform. 2023;5:lqad082.","journal-title":"NAR Genom Bioinform"},{"key":"4284_CR164","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nbt.1868","volume":"29","author":"AD Kostic","year":"2011","unstructured":"Kostic AD, Ojesina AI, Pedamallu CS, Jung J, Verhaak RG, Getz G, et al. PathSeq: software to identify or discover microbes by deep sequencing of human tissue. Nat Biotechnol. 2011;29:393\u20136.","journal-title":"Nat Biotechnol"},{"key":"4284_CR165","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.ccell.2026.01.007","volume":"44","author":"B Ghaddar","year":"2026","unstructured":"Ghaddar B, Blaser MJ, De S. Reliable detection of Host-Microbe Signatures in cancer using PRISM. Cancer Cell. 2026;44:879-890 e873.","journal-title":"Cancer Cell"},{"key":"4284_CR166","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/B978-0-12-418687-3.00023-9","volume":"529","author":"JS Dymond","year":"2013","unstructured":"Dymond JS. Explanatory chapter: quantitative PCR. Methods Enzymol. 2013;529:279\u201389.","journal-title":"Methods Enzymol"},{"key":"4284_CR167","doi-asserted-by":"publisher","DOI":"10.1016\/j.mocell.2024.100141","volume":"47","author":"D Bong","year":"2024","unstructured":"Bong D, Sohn J, Lee SV. Brief guide to RT-qPCR. Mol Cells. 2024;47:100141.","journal-title":"Mol Cells"},{"key":"4284_CR168","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s43018-026-01121-6","volume":"7","author":"SL Salzberg","year":"2026","unstructured":"Salzberg SL, Chia M, Tay A, de Miranda N, Smit V, Wesseling J, et al. Setting higher standards for reports of microbial species in human cancers. Nat Cancer. 2026;7:414\u201323.","journal-title":"Nat Cancer"},{"key":"4284_CR169","doi-asserted-by":"publisher","first-page":"4804","DOI":"10.1016\/j.csbj.2023.10.001","volume":"21","author":"R Zhou","year":"2023","unstructured":"Zhou R, Ng SK, Sung JJY, Goh WWB, Wong SH. Data pre-processing for analyzing microbiome data - a mini review. Comput Struct Biotechnol J. 2023;21:4804\u201315.","journal-title":"Comput Struct Biotechnol J"},{"key":"4284_CR170","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-57670-2","volume":"14","author":"B Wang","year":"2024","unstructured":"Wang B, Sun F, Luan Y. Comparison of the effectiveness of different normalization methods for metagenomic cross-study phenotype prediction under heterogeneity. Sci Rep. 2024;14:7024.","journal-title":"Sci Rep"},{"key":"4284_CR171","doi-asserted-by":"crossref","unstructured":"Chan LS, Li G. Zero is not absence: censoring-based differential abundance analysis for microbiome data. Bioinformatics. 2024;40:btae071.","DOI":"10.1093\/bioinformatics\/btae071"},{"key":"4284_CR172","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.677870","volume":"12","author":"Y Jasner","year":"2021","unstructured":"Jasner Y, Belogolovski A, Ben-Itzhak M, Koren O, Louzoun Y. Microbiome preprocessing machine learning pipeline. Front Immunol. 2021;12:677870.","journal-title":"Front Immunol"},{"key":"4284_CR173","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2489074","volume":"17","author":"P Li","year":"2025","unstructured":"Li P, Li M, Chen WH. Best practices for developing microbiome-based disease diagnostic classifiers through machine learning. Gut Microbes. 2025;17:2489074.","journal-title":"Gut Microbes"},{"key":"4284_CR174","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33071-9","volume":"13","author":"W Ling","year":"2022","unstructured":"Ling W, Lu J, Zhao N, Lulla A, Plantinga AM, Fu W, et al. Batch effects removal for microbiome data via conditional quantile regression. Nat Commun. 2022;13:5418.","journal-title":"Nat Commun"},{"key":"4284_CR175","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/s41564-025-01954-4","volume":"10","author":"GI Austin","year":"2025","unstructured":"Austin GI, Brown Kav A, ElNaggar S, Park H, Biermann J, Uhlemann AC, et al. Processing-bias correction with DEBIAS-M improves cross-study generalization of microbiome-based prediction models. Nat Microbiol. 2025;10:897\u2013911.","journal-title":"Nat Microbiol"},{"key":"4284_CR176","doi-asserted-by":"crossref","unstructured":"Teixeira M, Silva F, Ferreira RM, Pereira T, Figueiredo C, Oliveira HP. A review of machine learning methods for cancer characterization from microbiome data. NPJ Precis Oncol. 2024;8:123.\u00a0","DOI":"10.1038\/s41698-024-00617-7"},{"key":"4284_CR177","doi-asserted-by":"crossref","unstructured":"Topcuoglu BD, Lesniak NA, Ruffin MTt, Wiens J, Schloss PD. A framework for effective application of machine learning to microbiome-based classification problems. mBio. 2020;11:10.","DOI":"10.1128\/mBio.00434-20"},{"key":"4284_CR178","doi-asserted-by":"crossref","unstructured":"Gao XF, Zhang CG, Huang K, Zhao XL, Liu YQ, Wang ZK, et al. An oral microbiota-based deep neural network model for risk stratification and prognosis prediction in gastric cancer. J Oral Microbiol. 2025;17:2451921.","DOI":"10.1080\/20002297.2025.2451921"},{"key":"4284_CR179","doi-asserted-by":"crossref","unstructured":"Sun J, Fan Z, Sriram A, Park HJ. Unveiling the gut microbiome network fingerprint: a deep learning approach to predict immunotherapy response in melanoma patients. bioRxiv. 2024:2024.2010.2021.619471.","DOI":"10.1101\/2024.10.21.619471"},{"key":"4284_CR180","doi-asserted-by":"crossref","unstructured":"Fan X, He ZH, Guo J, Bu DC, Han DC, Qu XC, et al. Leveraging TME features and multi-omics data with an advanced deep learning framework for improved cancer survival prediction. Sci Rep. 2025;15:14282.\u00a0","DOI":"10.1038\/s41598-025-98565-0"},{"key":"4284_CR181","doi-asserted-by":"crossref","unstructured":"Cui Z, Wu Y, Zhang QH, Wang SG, He Y, Huang DS. MV-CVIB: a microbiome-based multi-view convolutional variational information bottleneck for predicting metastatic colorectal cancer. Front Microbiol. 2023;14:1238199.","DOI":"10.3389\/fmicb.2023.1238199"},{"key":"4284_CR182","doi-asserted-by":"publisher","DOI":"10.1016\/j.patter.2022.100658","volume":"4","author":"WX Shen","year":"2023","unstructured":"Shen WX, Liang SR, Jiang YY, Chen YZ. Enhanced metagenomic deep learning for disease prediction and consistent signature recognition by restructured microbiome 2D representations. Patterns (N Y). 2023;4:100658.","journal-title":"Patterns (N Y)"},{"key":"4284_CR183","unstructured":"Yoo H, Rosen G. Abundance-aware set transformer for microbiome sample embedding. arXiv preprint arXiv:250811075. 2025."},{"key":"4284_CR184","doi-asserted-by":"crossref","unstructured":"Zhang YL, Zhang HH, Liu BQ, Ning K. Highly accurate diagnosis of pancreatic cancer by integrative modeling using gut microbiome and exposome data. iScience. 2024;27:109294.\u00a0","DOI":"10.1016\/j.isci.2024.109294"},{"key":"4284_CR185","doi-asserted-by":"crossref","unstructured":"Liao HR, Shang JY, Sun YN. GDmicro: classifying host disease status with GCN and deep adaptation network based on the human gut microbiome data. Bioinformatics. 2023;39:btad747.\u00a0","DOI":"10.1093\/bioinformatics\/btad747"},{"key":"4284_CR186","doi-asserted-by":"crossref","unstructured":"Liu ZQ, Sun YH, Li YJ, Ma AJ, Willaims NF, Jahanbahkshi S, et al. An explainable graph neural framework to identify cancer-associated intratumoral microbial communities. Adv Sci. 2024;11:2403393.\u00a0","DOI":"10.1002\/advs.202403393"},{"key":"4284_CR187","doi-asserted-by":"crossref","unstructured":"Oh M, Zhang LQ. DeepGeni: deep generalized interpretable autoencoder elucidates gut microbiota for better cancer immunotherapy. Sci Rep. 2023;13:4599.\u00a0","DOI":"10.1038\/s41598-023-31210-w"},{"key":"4284_CR188","doi-asserted-by":"crossref","unstructured":"Grazioli F, Siarheyeu R, Alqassem I, Henschel A, Pileggi G, Meiser A. Microbiome-based disease prediction with multimodal variational information bottlenecks. PLoS Comput Biol. 2022;18:e1010050.\u00a0","DOI":"10.1371\/journal.pcbi.1010050"},{"key":"4284_CR189","doi-asserted-by":"publisher","first-page":"23565","DOI":"10.1109\/ACCESS.2021.3050838","volume":"9","author":"M Mulenga","year":"2021","unstructured":"Mulenga M, Kareem SA, Sabri AQM, Seera M, Govind S, Samudi C, et al. Feature extension of gut microbiome data for deep neural network-based colorectal cancer classification. IEEE Access. 2021;9:23565\u201378.","journal-title":"IEEE Access"},{"key":"4284_CR190","doi-asserted-by":"crossref","unstructured":"Oh M, Zhang LQ. DeepMicro: deep representation learning for disease prediction based on microbiome data. Sci Rep. 2020;10:6026.","DOI":"10.1038\/s41598-020-63159-5"},{"key":"4284_CR191","doi-asserted-by":"crossref","unstructured":"Zhang H, Zhang Y, Kang Z, Xiong J, Yang R, Ning K. MGM as a Large-Scale Pretrained Foundation Model for Microbiome Analyses in Diverse Contexts. Advanced Science. 2026;13(24):e13333.","DOI":"10.1002\/advs.202513333"},{"key":"4284_CR192","doi-asserted-by":"crossref","unstructured":"Medearis NA, Zhu S, Zomorrodi AR. BiomeGPT: a foundation model for the human gut microbiome. bioRxiv. 2026:2026.2001.2005.697599.","DOI":"10.64898\/2026.01.05.697599"},{"key":"4284_CR193","doi-asserted-by":"crossref","unstructured":"Wu W, Zhou Z, Riley R, Abdulqader M, Song X, Kautsar S, et al. Uncovering the genomic manifold via scalable learning from the global microbiome. bioRxiv. 2025:2025.2001.2030.635558.","DOI":"10.1101\/2025.01.30.635558"},{"key":"4284_CR194","doi-asserted-by":"crossref","unstructured":"Brixi G, Durrant MG, Ku J, Naghipourfar M, Poli M, Sun G, et al. Genome modelling and design across all domains of life with Evo 2. Nature. 2026;652:1\u201313.","DOI":"10.1038\/s41586-026-10176-5"},{"key":"4284_CR195","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1038\/s41586-025-10014-0","volume":"649","author":"Z Avsec","year":"2026","unstructured":"Avsec Z, Latysheva N, Cheng J, Novati G, Taylor KR, Ward T, et al. Advancing regulatory variant effect prediction with AlphaGenome. Nature. 2026;649:1206\u201318.","journal-title":"Nature"},{"key":"4284_CR196","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-023-02858-4","volume":"24","author":"R Rynazal","year":"2023","unstructured":"Rynazal R, Fujisawa K, Shiroma H, Salim F, Mizutani S, Shiba S, et al. Leveraging explainable AI for gut microbiome-based colorectal cancer classification. Genome Biol. 2023;24:21.","journal-title":"Genome Biol"},{"key":"4284_CR197","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s41591-019-0458-7","volume":"25","author":"S Yachida","year":"2019","unstructured":"Yachida S, Mizutani S, Shiroma H, Shiba S, Nakajima T, Sakamoto T, et al. Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer. Nat Med. 2019;25:968\u201376.","journal-title":"Nat Med"},{"key":"4284_CR198","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34405-3","volume":"13","author":"Q Su","year":"2022","unstructured":"Su Q, Liu Q, Lau RI, Zhang J, Xu Z, Yeoh YK, et al. Faecal microbiome-based machine learning for multi-class disease diagnosis. Nat Commun. 2022;13:6818.","journal-title":"Nat Commun"},{"key":"4284_CR199","doi-asserted-by":"crossref","unstructured":"Lei W, Zhou K, Lei Y, Li Q, Zhu H. Gut microbiota shapes cancer immunotherapy responses. npj Biofilms Microbiomes. 2025;11(1):143.","DOI":"10.1038\/s41522-025-00786-8"},{"key":"4284_CR200","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-082323-114522","author":"HM Zarour","year":"2025","unstructured":"Zarour HM, Trinchieri G. Harnessing the microbiome in cancer immunotherapy: regulation, prediction, and therapeutic targeting. Annu Rev Immunol. 2025. https:\/\/doi.org\/10.1146\/annurev-immunol-082323-114522.","journal-title":"Annu Rev Immunol"},{"key":"4284_CR201","doi-asserted-by":"crossref","unstructured":"Shi W, Shen LJ, Zou W, Wang JW, Yang JN, Wang YZ, et al. The gut microbiome is associated with therapeutic responses and toxicities of neoadjuvant chemoradiotherapy in rectal cancer patients-a pilot study. Front Cell Infect Microbiol. 2020;10:562463.\u00a0","DOI":"10.3389\/fcimb.2020.562463"},{"key":"4284_CR202","doi-asserted-by":"crossref","unstructured":"Oh M, Zhang LQ. Generalizing predictions to unseen sequencing profiles via deep generative models. Sci Rep. 2022;12:7151.\u00a0","DOI":"10.1038\/s41598-022-11363-w"},{"key":"4284_CR203","doi-asserted-by":"crossref","unstructured":"Jayakrishnan TT, Sangwan N, Barot SV, Farha N, Mariam A, Xiang S, et al. Multi-omics machine learning to study host-microbiome interactions in early-onset colorectal cancer. NPJ Precis Oncol. 2024;8:146.\u00a0","DOI":"10.1038\/s41698-024-00647-1"},{"key":"4284_CR204","doi-asserted-by":"crossref","unstructured":"Zhang SL, Cheng LS, Zhang ZY, Sun HT, Li JJ. Untangling determinants of gut microbiota and tumor immunologic status through a multi-omics approach in colorectal cancer. Pharmacol Res. 2023;188:106633.\u00a0","DOI":"10.1016\/j.phrs.2022.106633"},{"key":"4284_CR205","doi-asserted-by":"crossref","unstructured":"Tong SH, Huang KA, Xing WP, Chu YW, Nie CQ, Ji L, et al. Unveiling the distinctive variations in multi-omics triggered by TP53 mutation in lung cancer subtypes: an insight from interaction among intratumoral microbiota, tumor microenvironment, and pathology. Comput Biol Chem. 2024;113:108274.","DOI":"10.1016\/j.compbiolchem.2024.108274"},{"key":"4284_CR206","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1539653","volume":"16","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Han W, Feng Y, Wang Y, Liu X, Sun T, et al. Revealing gut microbiota biomarkers associated with melanoma immunotherapy response and key bacteria-fungi interaction relationships: evidence from metagenomics, machine learning, and SHAP methodology. Front Immunol. 2025;16:1539653.","journal-title":"Front Immunol"},{"key":"4284_CR207","doi-asserted-by":"crossref","unstructured":"Novielli P, Romano D, Magarelli M, Di Bitonto P, Diacono D, Chiatante A, et al. Explainable artificial intelligence for microbiome data analysis in colorectal cancer biomarker identification. Front Microbiol. 2024;15:1348974.\u00a0","DOI":"10.3389\/fmicb.2024.1348974"},{"key":"4284_CR208","doi-asserted-by":"crossref","unstructured":"Khelfaoui I, Wang WX, Meskher H, Shehata AI, El Basuini MF, Abouelenein MF, et al. Beyond just correlation: causal machine learning for the microbiome, from prediction to health policy with econometric tools. Front Microbiol. 2025;16:1691503.","DOI":"10.3389\/fmicb.2025.1691503"},{"key":"4284_CR209","doi-asserted-by":"publisher","DOI":"10.1186\/s13040-025-00422-3","volume":"18","author":"H Koh","year":"2025","unstructured":"Koh H, Kim J, Jang H. MiCML: a causal machine learning cloud platform for the analysis of treatment effects using microbiome profiles. BioData Min. 2025;18:10.","journal-title":"BioData Min"},{"key":"4284_CR210","doi-asserted-by":"crossref","unstructured":"Fan Z, Kernan KF, Sriram A, Benos PV, Canna SW, Carcillo JA, et al. Deep neural networks with knockoff features identify nonlinear causal relations and estimate effect sizes in complex biological systems. Gigascience. 2022;12:giad044.\u00a0","DOI":"10.1093\/gigascience\/giad044"},{"key":"4284_CR211","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46150-w","volume":"15","author":"M Rosenblatt","year":"2024","unstructured":"Rosenblatt M, Tejavibulya L, Jiang R, Noble S, Scheinost D. Data leakage inflates prediction performance in connectome-based machine learning models. Nat Commun. 2024;15:1829.","journal-title":"Nat Commun"},{"key":"4284_CR212","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-024-03401-9","volume":"25","author":"Y Yu","year":"2024","unstructured":"Yu Y, Mai Y, Zheng Y, Shi L. Assessing and mitigating batch effects in large-scale omics studies. Genome Biol. 2024;25:254.","journal-title":"Genome Biol"},{"key":"4284_CR213","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adp6040","volume":"10","author":"S Orouji","year":"2024","unstructured":"Orouji S, Liu MC, Korem T, Peters MAK. Domain adaptation in small-scale and heterogeneous biological datasets. Sci Adv. 2024;10:eadp6040.","journal-title":"Sci Adv"},{"key":"4284_CR214","doi-asserted-by":"publisher","DOI":"10.1093\/bioadv\/vbad048","volume":"3","author":"MJ Lewis","year":"2023","unstructured":"Lewis MJ, Spiliopoulou A, Goldmann K, Pitzalis C, McKeigue P, Barnes MR. Nestedcv: an R package for fast implementation of nested cross-validation with embedded feature selection designed for transcriptomics and high-dimensional data. Bioinformatics Adv. 2023;3:vbad048.","journal-title":"Bioinformatics Adv"},{"key":"4284_CR215","doi-asserted-by":"publisher","DOI":"10.1016\/j.spasta.2024.100843","volume":"62","author":"A Adin","year":"2024","unstructured":"Adin A, Krainski ET, Lenzi A, Liu Z, Mart\u00ednez-Minaya J, Rue H. Automatic cross-validation in structured models: is it time to leave out leave-one-out? Spat Stat. 2024;62:100843.","journal-title":"Spat Stat"},{"key":"4284_CR216","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1038\/s41591-021-01552-x","volume":"27","author":"C Mirzayi","year":"2021","unstructured":"Mirzayi C, Renson A, Genomic Standards C, Massive A, Quality Control S, Zohra F, et al. Reporting guidelines for human microbiome research: the STORMS checklist. Nat Med. 2021;27:1885\u201392.","journal-title":"Nat Med"},{"key":"4284_CR217","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41586-020-2881-9","volume":"587","author":"I Vujkovic-Cvijin","year":"2020","unstructured":"Vujkovic-Cvijin I, Sklar J, Jiang LJ, Natarajan L, Knight R, Belkaid Y. Host variables confound gut microbiota studies of human disease. Nature. 2020;587:448.","journal-title":"Nature"},{"key":"4284_CR218","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/s41591-024-02963-2","volume":"30","author":"RY Tito","year":"2024","unstructured":"Tito RY, Verbandt S, Vazquez MA, Lahti L, Verspecht C, Llor\u00e9ns-Rico V, et al. Microbiome confounders and quantitative profiling challenge predicted microbial targets in colorectal cancer development. Nat Med. 2024;30:1339\u201348.","journal-title":"Nat Med"},{"key":"4284_CR219","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13059-020-02037-9","volume":"21","author":"SS Manzoor","year":"2020","unstructured":"Manzoor SS, Doedens A, Burns MB. The promise and challenge of cancer microbiome research. Genome Biol. 2020;21:131.","journal-title":"Genome Biol"},{"key":"4284_CR220","doi-asserted-by":"crossref","unstructured":"Zhao LY, Mei JX, Yu G, Lei L, Zhang WH, Liu K, et al. Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications. Signal Transduct Target Ther. 2023;8(1):201.","DOI":"10.1038\/s41392-023-01406-7"},{"key":"4284_CR221","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12:31\u201346.","journal-title":"Cancer Discov"},{"key":"4284_CR222","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115358","volume":"44","author":"P P\u00e9rez Escriva","year":"2025","unstructured":"P\u00e9rez Escriva P, Correia Tavares Bernardino C, Letellier E. De-coding the complex role of microbial metabolites in cancer. Cell Rep. 2025;44:115358.","journal-title":"Cell Rep"},{"key":"4284_CR223","doi-asserted-by":"crossref","unstructured":"El Tekle G, Garrett WS. Bacteria in cancer initiation, promotion and progression. Nat Rev Cancer. 2023;23(9):600\u2013618.","DOI":"10.1038\/s41568-023-00594-2"},{"key":"4284_CR224","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2038865","volume":"14","author":"K Jaye","year":"2022","unstructured":"Jaye K, Li CG, Chang D, Bhuyan DJ. The role of key gut microbial metabolites in the development and treatment of cancer. Gut Microbes. 2022;14:2038865.","journal-title":"Gut Microbes"},{"key":"4284_CR225","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2203968","volume":"15","author":"Y Liu","year":"2023","unstructured":"Liu Y, Lau HCH, Yu J. Microbial metabolites in colorectal tumorigenesis and cancer therapy. Gut Microbes. 2023;15:2203968.","journal-title":"Gut Microbes"},{"key":"4284_CR226","doi-asserted-by":"crossref","unstructured":"Fang Y, Liu X, Ren J, Wang X, Zhou F, Huang S, et al. Integrated analysis of microbiome and metabolome reveals signatures in PDAC tumorigenesis and prognosis. Microbiol Spectr. 2024;12:e00962.\u00a0","DOI":"10.1128\/spectrum.00962-24"},{"key":"4284_CR227","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-024-00612-7","volume":"10","author":"Y Ma","year":"2024","unstructured":"Ma Y, Liu L. NMFGOT: a multi-view learning framework for the microbiome and metabolome integrative analysis with optimal transport plan. NPJ Biofilms Microbiomes. 2024;10:135.","journal-title":"NPJ Biofilms Microbiomes"},{"key":"4284_CR228","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1158\/0008-5472.CAN-24-2580","volume":"85","author":"T Zhang","year":"2025","unstructured":"Zhang T, Li Y, Zhai E, Zhao R, Qian Y, Huang Z, et al. Intratumoral Fusobacterium nucleatum recruits tumor-associated neutrophils to promote gastric cancer progression and immune evasion. Cancer Res. 2025;85:1819\u201341.","journal-title":"Cancer Res"},{"key":"4284_CR229","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1158\/2159-8290.CD-20-0537","volume":"11","author":"S Parida","year":"2021","unstructured":"Parida S, Wu S, Siddharth S, Wang G, Muniraj N, Nagalingam A, et al. A procarcinogenic colon microbe promotes breast tumorigenesis and metastatic progression and concomitantly activates notch and b-catenin axes. Cancer Discov. 2021;11:1138\u201357.","journal-title":"Cancer Discov"},{"key":"4284_CR230","doi-asserted-by":"crossref","unstructured":"B\u00f6hm D, Russ E, Guchelaar HJ, Ziemons J, Penders J, Smidt ML, et al. The role of the gut microbiota in chemotherapy response, efficacy and toxicity: a systematic review. npj Precis Oncol. 2025;9(1):265.","DOI":"10.1038\/s41698-025-01034-0"},{"key":"4284_CR231","doi-asserted-by":"crossref","unstructured":"Otto-Dobos LD, Strehle LD, Loman BR, Seng MM, Sardesai SD, Williams NO, et al. Baseline gut microbiome alpha diversity predicts chemotherapy-induced gastrointestinal symptoms in patients with breast cancer. npj Breast Cancer. 2024;10(1):99.","DOI":"10.1038\/s41523-024-00707-6"},{"key":"4284_CR232","doi-asserted-by":"publisher","first-page":"1507336","DOI":"10.3389\/fmicb.2025.1507336","volume":"16","author":"Y Huang","year":"2025","unstructured":"Huang Y, Liao L, Jiang Y, Tao S, Tang D. Role of gut microbiota in predicting chemotherapy-induced neutropenia duration in leukemia patients. Front Microbiol. 2025;16:1507336\u20131507336.","journal-title":"Front Microbiol"},{"key":"4284_CR233","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1186\/s12885-025-15309-z","volume":"25","author":"Y Li","year":"2025","unstructured":"Li Y, Liu S, Lai X, Yang D. Analysis of the predictive effect of gut microbiota changes on the occurrence of chemotherapy resistance in pancreatic cancer patients based on nomogram prediction models. BMC Cancer. 2025;25:1913\u20131913.","journal-title":"BMC Cancer"},{"key":"4284_CR234","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00930-25","volume":"16","author":"LE Hillege","year":"2025","unstructured":"Hillege LE, Trepka KR, Guthrie BGH, Fu X, Aarnoutse R, Paymar MR, et al. Microbial vitamin biosynthesis links gut microbiota dynamics to chemotherapy toxicity. MBio. 2025;16:e00930-00925.","journal-title":"MBio"},{"key":"4284_CR235","doi-asserted-by":"crossref","unstructured":"Sadeghloo Z, Sadeghi A. Gut microbiota as a hidden modulator of chemotherapy: implications for colorectal cancer treatment. Discov Oncol. 2025;16(1):1717.","DOI":"10.1007\/s12672-025-03574-0"},{"key":"4284_CR236","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.cell.2017.07.008","volume":"170","author":"TC Yu","year":"2017","unstructured":"Yu TC, Guo F, Yu Y, Sun T, Ma D, Han J, et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell. 2017;170:548.","journal-title":"Cell"},{"key":"4284_CR237","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.chom.2025.05.004","volume":"33","author":"X Ding","year":"2025","unstructured":"Ding X, Ting NLN, Wong CC, Huang P, Jiang L, Liu C, et al. Bacteroides fragilis promotes chemoresistance in colorectal cancer, and its elimination by phage VA7 restores chemosensitivity. Cell Host Microbe. 2025;33:941-956.e910.","journal-title":"Cell Host Microbe"},{"key":"4284_CR238","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1124\/dmd.121.000669","volume":"50","author":"P Dhurjad","year":"2022","unstructured":"Dhurjad P, Dhavaliker C, Gupta K, Sonti R. Exploring drug metabolism by the gut microbiota: modes of metabolism and experimental approaches. Drug Metab Dispos. 2022;50:224\u201334.","journal-title":"Drug Metab Dispos"},{"key":"4284_CR239","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.trsl.2016.08.002","volume":"179","author":"ID Wilson","year":"2016","unstructured":"Wilson ID, Nicholson JK. Gut microbiome interactions with drug metabolism, efficacy and toxicity. Transl Res. 2016;179:204\u2013204.","journal-title":"Transl Res"},{"key":"4284_CR240","doi-asserted-by":"crossref","unstructured":"Kl\u00fcnemann M, Andrejev S, Blasche S, Mateus A, Phapale P, Devendran S, et al. Bioaccumulation of therapeutic drugs by human gut bacteria. Nature. 2021;597(7877):533\u2013538.","DOI":"10.1038\/s41586-021-03891-8"},{"key":"4284_CR241","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41586-019-1291-3","volume":"570","author":"M Zimmermann","year":"2019","unstructured":"Zimmermann M, Zimmermann-Kogadeeva M, Wegmann R, Goodman AL. Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature. 2019;570:462\u20137.","journal-title":"Nature"},{"key":"4284_CR242","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1126\/science.1191175","volume":"330","author":"BD Wallace","year":"2010","unstructured":"Wallace BD, Wang H, Lane KT, Scott JE, Orans J, Koo JS, et al. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science. 2010;330:831\u20135.","journal-title":"Science"},{"key":"4284_CR243","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1021\/acschembio.9b00788","volume":"15","author":"PB Jariwala","year":"2019","unstructured":"Jariwala PB, Pellock SJ, Cloer EW, Artola M, Simpson JB, Bhatt AP, et al. Discovering the microbial enzymes driving drug toxicity with activity-based protein profiling. ACS Chem Biol. 2019;15:217\u2013217.","journal-title":"ACS Chem Biol"},{"key":"4284_CR244","doi-asserted-by":"crossref","unstructured":"Guthrie L, Gupta S, Daily J, Kelly L. Human microbiome signatures of differential colorectal cancer drug metabolism. npj Biofilms Microbiomes. 2017;3(1):27.","DOI":"10.1038\/s41522-017-0034-1"},{"key":"4284_CR245","doi-asserted-by":"publisher","first-page":"7374","DOI":"10.1073\/pnas.1918095117","volume":"117","author":"AP Bhatt","year":"2020","unstructured":"Bhatt AP, Pellock SJ, Biernat KA, Walton WG, Wallace BD, Creekmore BC, et al. Targeted inhibition of gut bacterial \u03b2-glucuronidase activity enhances anticancer drug efficacy. Proc Natl Acad Sci U S A. 2020;117:7374\u201381.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4284_CR246","doi-asserted-by":"crossref","unstructured":"Lin HY, Chen CY, Lin TC, Yeh LF, Hsieh WC, Gao S, et al. Entropy-driven binding of gut bacterial \u03b2-glucuronidase inhibitors ameliorates irinotecan-induced toxicity. Commun Biol. 2021;4(1):280.","DOI":"10.1038\/s42003-021-01815-w"},{"key":"4284_CR247","doi-asserted-by":"crossref","unstructured":"Cheatham SM, Rehman Z, Arastonejad M, Kane R, Ahmad N, Luffman N, et al. Butyrate prevents chemotherapy-induced gastrointestinal toxicity and microbial dysbiosis. Sci Rep. 2025;16(1):785.","DOI":"10.1038\/s41598-025-30385-8"},{"key":"4284_CR248","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1001\/jamaoncol.2019.2785","volume":"5","author":"DJ Pinato","year":"2019","unstructured":"Pinato DJ, Howlett S, Ottaviani D, Urus H, Patel A, Mineo T, et al. Association of prior antibiotic treatment with survival and response to immune checkpoint inhibitor therapy in patients with cancer. JAMA Oncol. 2019;5:1774\u20131774.","journal-title":"JAMA Oncol"},{"key":"4284_CR249","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.140940","volume":"5","author":"A Limeta","year":"2020","unstructured":"Limeta A, Ji B, Levin M, Gatto F, Nielsen J. Meta-analysis of the gut microbiota in predicting response to cancer immunotherapy in metastatic melanoma. JCI Insight. 2020;5:e140940-e140940.","journal-title":"JCI Insight"},{"key":"4284_CR250","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1312","volume":"13","author":"Z Han","year":"2023","unstructured":"Han Z, Cheng S, Dai D, Kou Y, Zhang X, Li F, et al. The gut microbiome affects response of treatments in HER2\u2010negative advanced gastric cancer. Clin Transl Med. 2023;13:e1312-e1312.","journal-title":"Clin Transl Med"},{"key":"4284_CR251","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1111\/1759-7714.15303","volume":"15","author":"S Ren","year":"2024","unstructured":"Ren S, Feng L, Liu H, Mao Y, Yu Z. Gut microbiome affects the response to immunotherapy in non-small cell lung cancer. Thorac Cancer. 2024;15:1149\u201363.","journal-title":"Thorac Cancer"},{"key":"4284_CR252","doi-asserted-by":"publisher","first-page":"876","DOI":"10.18632\/oncotarget.28252","volume":"13","author":"H Liang","year":"2022","unstructured":"Liang H, Jo JH, Zhang Z, MacGibeny MA, Han J, Proctor DM, et al. Predicting cancer immunotherapy response from gut microbiomes using machine learning models. Oncotarget. 2022;13:876\u2013876.","journal-title":"Oncotarget"},{"key":"4284_CR253","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s43018-025-01067-1","volume":"7","author":"NL Silver","year":"2026","unstructured":"Silver NL, Dai J, Kerr TD, Altemus J, Garg R, Simmons H, et al. Intratumoral bacteria are immunosuppressive and promote immunotherapy resistance in head and neck squamous cell carcinoma. Nat Cancer. 2026;7:80\u201397.","journal-title":"Nat Cancer"},{"key":"4284_CR254","volume":"14","author":"X Liu","year":"2023","unstructured":"Liu X, Tang H, Zhou Q, Zeng Y, Lu B, Chen D, et al. Gut microbiota composition in patients with advanced malignancies experiencing immune-related adverse events. Front Immunol. 2023;14:1109281-1109281.","journal-title":"Front Immunol"},{"key":"4284_CR255","doi-asserted-by":"crossref","unstructured":"Dravillas C, Williams N, Husain M, Hoyd R, Hussein A, Meara A, et al. The association of the microbiome with melanoma tumor response to immune checkpoint inhibitor treatment and immune-related adverse events (NCT05102773). medRxiv. 2025:2025.2001.2030.25321413-25322025.25321401.25321430.25321413.","DOI":"10.1101\/2025.01.30.25321413"},{"key":"4284_CR256","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.chom.2024.03.002","volume":"32","author":"X Zhu","year":"2024","unstructured":"Zhu X, Huang X, Hu M, Sun R, Li J, Wang H, et al. A specific enterotype derived from gut microbiome of older individuals enables favorable responses to immune checkpoint blockade therapy. Cell Host Microbe. 2024;32:489-505.e485.","journal-title":"Cell Host Microbe"},{"key":"4284_CR257","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1186\/s12916-025-04230-8","volume":"23","author":"Z Shi","year":"2025","unstructured":"Shi Z, Jiang W, Li H, Zhang Y, Xue W, Wang Y, et al. Faecalibacterium prausnitzii promotes anti-PD-L1 efficacy in natural killer\/T-cell lymphoma by enhancing antitumor immunity. BMC Med. 2025;23:387\u2013387.","journal-title":"BMC Med"},{"key":"4284_CR258","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.aac4255","volume":"350","author":"A Sivan","year":"2015","unstructured":"Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, Earley ZM, et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science. 2015;350:1084\u20139.","journal-title":"Science"},{"key":"4284_CR259","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.772532","volume":"12","author":"G Gao","year":"2021","unstructured":"Gao G, Ma T, Zhang T, Jin H, Li Y, Kwok LY, et al. Adjunctive probiotic Lactobacillus rhamnosus Probio-M9 administration enhances the effect of anti-PD-1 antitumor therapy via restoring antibiotic-disrupted gut microbiota. Front Immunol. 2021;12:772532-772532.","journal-title":"Front Immunol"},{"key":"4284_CR260","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abn0704","volume":"7","author":"G Mirji","year":"2022","unstructured":"Mirji G, Worth A, Bhat SA, El Sayed M, Kannan T, Goldman AR, et al. The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer. Sci Immunol. 2022;7:eabn0704-eabn0704.","journal-title":"Sci Immunol"},{"key":"4284_CR261","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.3389\/fimmu.2019.01235","volume":"10","author":"T Wang","year":"2019","unstructured":"Wang T, Zheng N, Luo Q, Jiang L, He B, Yuan X, et al. Probiotics lactobacillus reuteri abrogates immune checkpoint blockade-associated colitis by inhibiting group 3 innate lymphoid cells. Front Immunol. 2019;10:1235\u20131235.","journal-title":"Front Immunol"},{"key":"4284_CR262","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1073\/pnas.1712901115","volume":"115","author":"F Wang","year":"2018","unstructured":"Wang F, Yin Q, Chen L, Davis MM. Bifidobacterium can mitigate intestinal immunopathology in the context of CTLA-4 blockade. Proc Natl Acad Sci U S A. 2018;115:157\u201361.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4284_CR263","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.cell.2018.07.038","volume":"174","author":"MA Fischbach","year":"2018","unstructured":"Fischbach MA. Microbiome: focus on causation and mechanism. Cell. 2018;174:785\u201390.","journal-title":"Cell"},{"key":"4284_CR264","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1093\/jnci\/93.14.1054","volume":"93","author":"MS Pepe","year":"2001","unstructured":"Pepe MS, Etzioni R, Feng Z, Potter JD, Thompson ML, Thornquist M, et al. Phases of biomarker development for early detection of cancer. J Natl Cancer Inst. 2001;93:1054\u201361.","journal-title":"J Natl Cancer Inst"},{"key":"4284_CR265","doi-asserted-by":"publisher","first-page":"100948","DOI":"10.1016\/j.lanmic.2024.07.011","volume":"6","author":"J Rodriguez","year":"2025","unstructured":"Rodriguez J, Hassani Z, Alves Costa Silva C, Betsou F, Carraturo F, Fasano A, et al. State of the art and the future of microbiome-based biomarkers: a multidisciplinary Delphi consensus. Lancet Microbe. 2025;6:100948.","journal-title":"Lancet Microbe"},{"key":"4284_CR266","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41591-022-01695-5","volume":"28","author":"KA Lee","year":"2022","unstructured":"Lee KA, Thomas AM, Bolte LA, Bjork JR, de Ruijter LK, Armanini F, et al. Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma. Nat Med. 2022;28:535\u201344.","journal-title":"Nat Med"},{"key":"4284_CR267","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41591-022-01698-2","volume":"28","author":"JA McCulloch","year":"2022","unstructured":"McCulloch JA, Davar D, Rodrigues RR, Badger JH, Fang JR, Cole AM, et al. Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1. Nat Med. 2022;28:545\u201356.","journal-title":"Nat Med"},{"key":"4284_CR268","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1126\/science.abf3363","volume":"371","author":"D Davar","year":"2021","unstructured":"Davar D, Dzutsev AK, McCulloch JA, Rodrigues RR, Chauvin JM, Morrison RM, et al. Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients. Science. 2021;371:595\u2013602.","journal-title":"Science"},{"key":"4284_CR269","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1038\/s41591-023-02453-x","volume":"29","author":"B Routy","year":"2023","unstructured":"Routy B, Lenehan JG, Miller WH Jr, Jamal R, Messaoudene M, Daisley BA, et al. Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial. Nat Med. 2023;29:2121\u201332.","journal-title":"Nat Med"},{"key":"4284_CR270","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-097802","volume":"15","author":"C Rauber","year":"2025","unstructured":"Rauber C, Roberti MP, Vehreschild MJ, Tsakmaklis A, Springfeld C, Teufel A, et al. Protocol: faecal microbiota transfer in liver cancer to overcome resistance to atezolizumab\/bevacizumab - a multicentre, randomised, placebo-controlled, double-blind phase II trial (the FLORA trial). BMJ Open. 2025;15:e097802.","journal-title":"BMJ Open"},{"key":"4284_CR271","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41591-022-01694-6","volume":"28","author":"N Dizman","year":"2022","unstructured":"Dizman N, Meza L, Bergerot P, Alcantara M, Dorff T, Lyou Y, et al. Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial. Nat Med. 2022;28:704\u201312.","journal-title":"Nat Med"},{"key":"4284_CR272","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1038\/s41591-024-03086-4","volume":"30","author":"H Ebrahimi","year":"2024","unstructured":"Ebrahimi H, Dizman N, Meza L, Malhotra J, Li X, Dorff T, et al. Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial. Nat Med. 2024;30:2576\u201385.","journal-title":"Nat Med"},{"key":"4284_CR273","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1056\/NEJMoa1910437","volume":"381","author":"Z DeFilipp","year":"2019","unstructured":"DeFilipp Z, Bloom PP, Torres Soto M, Mansour MK, Sater MRA, Huntley MH, et al. Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant. N Engl J Med. 2019;381:2043\u201350.","journal-title":"N Engl J Med"},{"key":"4284_CR274","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41591-024-02803-3","volume":"30","author":"JR Bj\u00f6rk","year":"2024","unstructured":"Bj\u00f6rk JR, Bolte LA, Thomas AM, Lee KA, Rossi N, Wind TT, et al. Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma. Nat Med. 2024;30:785\u201396.","journal-title":"Nat Med"},{"key":"4284_CR275","unstructured":"FDA approves first fecal microbiota product.\u00a0https:\/\/www.fda.gov\/vaccines-blood-biologics\/vaccines\/rebyota?utm_source=chatgpt.com."},{"key":"4284_CR276","unstructured":"FDA approves first orally administered fecal microbiota product for the prevention of recurrence of clostridioides difficile infection website title: FDA news release.\u00a0https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-orally-administered-fecal-microbiota-product-prevention-recurrence-clostridioides?utm_source=chatgpt.com."},{"key":"4284_CR277","doi-asserted-by":"crossref","unstructured":"Lu P, Gao Y, Peng WG, Zhang H, Zhu K, Robinson EK, et al. Eubiota: modular agentic AI for autonomous discovery in the gut microbiome. bioRxiv. 2026:2026.2002.2027.708412.","DOI":"10.64898\/2026.02.27.708412"},{"key":"4284_CR278","doi-asserted-by":"publisher","DOI":"10.1016\/j.patter.2025.101285","volume":"6","author":"H Husseini-Wusthoff","year":"2025","unstructured":"Husseini-Wusthoff H, Riethdorf S, Schneeweiss A, Trumpp A, Pantel K, Wikman H, et al. Cluster-based human-in-the-loop strategy for improving machine learning-based circulating tumor cell detection in liquid biopsy. Patterns (N Y). 2025;6:101285.","journal-title":"Patterns (N Y)"},{"issue":"228\u2013246","key":"4284_CR279","volume":"38","author":"B Meghdadi","year":"2026","unstructured":"Meghdadi B, Al-Holou WN, Scott AJ, Mittal A, Liang N, Sravya P, et al. Digital twins for in vivo metabolic flux estimations in patients with brain cancer. Cell Metab. 2026;38(228\u2013246):e217.","journal-title":"Cell Metab"},{"key":"4284_CR280","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/s41568-025-00850-7","volume":"25","author":"US Asghar","year":"2025","unstructured":"Asghar US, Chung C. Application of digital twins for personalized oncology. Nat Rev Cancer. 2025;25:823\u20135.","journal-title":"Nat Rev Cancer"},{"key":"4284_CR281","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmorw.2024.100056","volume":"5","author":"L Mollica","year":"2024","unstructured":"Mollica L, Leli C, Sottotetti F, Quaglini S, Locati LD, Marceglia S. Digital twins: a new paradigm in oncology in the era of big data. ESMO Real World Data Digit Oncol. 2024;5:100056.","journal-title":"ESMO Real World Data Digit Oncol"}],"container-title":["Genome Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13059-026-04284-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13059-026-04284-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13059-026-04284-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:03:43Z","timestamp":1789563823000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13059-026-04284-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":281,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4284"],"URL":"https:\/\/doi.org\/10.1186\/s13059-026-04284-8","relation":{},"ISSN":["1474-760X"],"issn-type":[{"value":"1474-760X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"13 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"291"}}